Clinical Trial Update: A Trial of Cabozantinib (XL184) and Gemcitabine in Advanced Pancreatic Cancer [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating cabozantinib in combination with gemcitabine for advanced pancreatic cancer has been completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Cancer

Drugs mentioned

• Gemcitabine (Gemcitabine)
• cabozantinib (cabozantinib)

Snippet

Sponsor: University of Michigan Rogel Cancer Center | Conditions: Pancreatic Cancer | Phase 1 | Status: COMPLETED | Results posted: 2018-09-19